Enlivex Therapeutics Ltd. (ENLV)

Enlivex Therapeutics Statistics

Total Valuation

ENLV has a market cap or net worth of $24.29 million. The enterprise value is $5.27 million.

Market Cap	24.29M
Enterprise Value	5.27M

Important Dates

The next estimated earnings date is Friday, November 28, 2025, after market close.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

ENLV has 24.29 million shares outstanding. The number of shares has increased by 21.10% in one year.

Current Share Class	24.29M
Shares Outstanding	24.29M
Shares Change (YoY)	+21.10%
Shares Change (QoQ)	+0.41%
Owned by Insiders (%)	4.52%
Owned by Institutions (%)	7.20%
Float	21.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.25
P/TBV Ratio	1.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.41, with a Debt / Equity ratio of 0.03.

Current Ratio	6.41
Quick Ratio	6.20
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -55.02% and return on invested capital (ROIC) is -38.78%.

Return on Equity (ROE)	-55.02%
Return on Assets (ROA)	-34.82%
Return on Invested Capital (ROIC)	-38.78%
Return on Capital Employed (ROCE)	-78.79%
Revenue Per Employee	n/a
Profits Per Employee	-$184,479
Employee Count	71
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.26% in the last 52 weeks. The beta is 1.48, so ENLV's price volatility has been higher than the market average.

Beta (5Y)	1.48
52-Week Price Change	-21.26%
50-Day Moving Average	1.07
200-Day Moving Average	1.09
Relative Strength Index (RSI)	37.37
Average Volume (20 Days)	145,814

Short Selling Information

Short Interest	173,179
Short Previous Month	264,402
Short % of Shares Out	0.75%
Short % of Float	n/a
Short Ratio (days to cover)	0.97

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-15.18M
Pretax Income	-13.10M
Net Income	-13.10M
EBITDA	-14.81M
EBIT	-15.18M
Earnings Per Share (EPS)	-$0.57

Balance Sheet

The company has $19.51 million in cash and $480,000 in debt, giving a net cash position of $19.03 million or $0.78 per share.

Cash & Cash Equivalents	19.51M
Total Debt	480,000
Net Cash	19.03M
Net Cash Per Share	$0.78
Equity (Book Value)	19.05M
Book Value Per Share	0.80
Working Capital	18.00M

Cash Flow

In the last 12 months, operating cash flow was -$12.52 million and capital expenditures -$83,000, giving a free cash flow of -$12.61 million.

Operating Cash Flow	-12.52M
Capital Expenditures	-83,000
Free Cash Flow	-12.61M
FCF Per Share	-$0.52

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ENLV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.10%
Shareholder Yield	-21.10%
Earnings Yield	-53.92%
FCF Yield	-51.89%

Analyst Forecast

The average price target for ENLV is $10.00, which is 900.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	900.00%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1